Kymera Therapeutics (KYMR) stock drops 6.6% to start 2026 as insider sale filing stays in focus

Kymera Therapeutics (KYMR) stock drops 6.6% to start 2026 as insider sale filing stays in focus

NEW YORK, Jan 3, 2026, 20:43 ET — Market closed Kymera Therapeutics shares slid on Friday, ending down 6.6% at $72.76 as the biotech underperformed its sector even as the broader market started 2026 on a mixed note. The move matters because Kymera has been a high-beta biotech name since a sharp rally in December on early trial data for its KT-621 immunology program, leaving the stock sensitive to profit-taking and fresh supply from capital-raising activity. Kymeratx With U.S. markets facing a busy week of economic releases, risk appetite has been uneven and investors have leaned on near-term catalysts —
Novanta stock tumbles 6.6% to start 2026; traders eye Jan. 14 management talks

Novanta stock tumbles 6.6% to start 2026; traders eye Jan. 14 management talks

NEW YORK, January 3, 2026, 20:47 ET — Market closed Novanta Inc. shares fell 6.6% on Friday, closing at $111.14 after touching an intraday low of $110.25, according to data from Twelve Data. Twelve Data The move stood out because it landed on the first trading day of 2026, when many investors were still returning from year-end breaks and liquidity can be thinner. U.S. stocks finished mixed in that session as Treasury yields rose. Reuters “Today is kind of a holiday trading day, lighter volumes, people not engaged normally,” said Jed Ellerbroek, portfolio manager at Argent Capital in St. Louis.
Paymentus stock ends first 2026 session down nearly 10% — what’s behind the sudden drop?

Paymentus stock ends first 2026 session down nearly 10% — what’s behind the sudden drop?

New York, Jan 3, 2026, 20:13 ET — Market closed Paymentus Holdings’ shares tumbled nearly 10% in the first U.S. trading session of 2026, ending Friday at $28.47. The stock traded as low as $28.22 intraday. Finviz The outsized move lands as investors shift positioning ahead of a busy January calendar that can reset interest-rate bets, a key driver for high-growth stocks. The monthly jobs report due Jan. 9 and the consumer price index on Jan. 13 are among the headline events, Reuters reported. Reuters “The market is looking for direction,” Matthew Maley, chief market strategist at Miller Tabak, told
Guidewire stock sinks 6.7%: GWRE slides below $190 as traders eye next earnings

Guidewire stock sinks 6.7%: GWRE slides below $190 as traders eye next earnings

New York, January 3, 2026, 20:07 ET — Market closed Shares of Guidewire Software fell 6.7% on Friday to $187.63, after swinging between $187.10 and $202.00 in the session. About 807,000 shares changed hands. The drop matters because Guidewire is a widely followed bet on insurers’ shift to cloud-based core systems, a transition investors have treated as a multi-year growth story. Rate expectations still loom over growth stocks, and sharp moves can follow when investors reassess how much they want to pay for earnings expected further out. For Guidewire, the focus is its shift from license sales to cloud subscriptions.
BILL stock drops 7% to start 2026 as rate jitters hit fintech; KBW lifts target

BILL stock drops 7% to start 2026 as rate jitters hit fintech; KBW lifts target

NEW YORK, January 3, 2026, 20:13 ET — Market closed Shares of BILL Holdings, Inc. fell 7.3% on Friday to $50.56, a sharp drop on the first U.S. trading session of 2026. The decline came as investors leaned toward value stocks and away from growth names while U.S. Treasury yields moved higher. The Dow and S&P 500 ended up on the day, while the Nasdaq dipped, according to Reuters data. Reuters That matters for BILL because the fintech is often priced like a growth software company, which can make it more sensitive to shifts in rate expectations early in the
Polestar stock slides 7% as investors eye Jan. 9 sales update after Geely-backed funding moves

Polestar stock slides 7% as investors eye Jan. 9 sales update after Geely-backed funding moves

New York, Jan 3, 2026, 8:05 PM ET — Market closed Polestar Automotive Holding UK PLC (PSNY) shares fell 7.3% on Friday to $19.81, finishing the last U.S. session lower with markets now shut for the weekend. The drop matters because Polestar is heading into a key data point on demand after a turbulent December that included a 1-for-30 reverse split and fresh funding announcements. Polestar has said it expects to report fourth-quarter retail sales volumes on Jan. 9. Investors have been tracking how quickly the Sweden-based electric-vehicle maker can shore up its balance sheet, after leaning on its majority
AppLovin stock today: APP slides 8% and breaks a key trend line — what traders watch next

AppLovin stock today: APP slides 8% and breaks a key trend line — what traders watch next

NEW YORK, January 3, 2026, 20:17 ET — Market closed AppLovin Corp (NASDAQ: APP) shares fell 8.2% on Friday to $618.32, extending a late-December pullback into the first trading day of 2026. The stock hit about $611 and ended below its 50-day moving average near $639, a closely watched momentum gauge, MarketBeat data showed. The drop marked a seventh straight session of losses since the stock hit an all-time high of $733.60 on Dec. 22, making it the worst performer in the S&P 500 on the day, Barron’s reported. AppLovin gained 108% in 2025, and the retreat has sharpened debate
Liquidia (LQDA) stock slides after heavy $30 put bets—what investors are watching next

Liquidia (LQDA) stock slides after heavy $30 put bets—what investors are watching next

NEW YORK, January 3, 2026, 20:03 ET — Market closed Liquidia Corp shares ended sharply lower on Friday, retreating about 9% to $31.40 and giving back ground after trading near a fresh 52-week high earlier in the session. The drop matters because it came on the first U.S. trading day of 2026, a period when investors often reset risk and rebalance exposure in small- and mid-cap healthcare names. Liquidia’s move was far larger than the broader biotech tape. Derivatives positioning added to the focus. Options activity flagged unusually heavy demand for bearish protection tied to $30, a strike that sits
CoreWeave (CRWV) stock today: Credit agreement amendment puts liquidity covenant in focus after Friday surge

CoreWeave (CRWV) stock today: Credit agreement amendment puts liquidity covenant in focus after Friday surge

NEW YORK, January 3, 2026, 20:10 ET — Market closed CoreWeave, Inc. said it amended a credit agreement tied to its DDTL 3.0 facility, a regulatory filing showed. TradingView Shares of the AI cloud provider closed Friday up 10.77% at $79.32, data showed. Investing The amendment lands as investors weigh how quickly debt-heavy AI infrastructure companies can keep adding capacity without tripping lender safeguards. Covenants — rules inside loan documents that require cash levels or financial ratios — can force a borrower to raise funding or curb spending if it falls short. DDTL stands for delayed-draw term loan, which lets
Spyre Therapeutics stock slides 6.6% after New Year session; $30 level and 2026 trial data in focus

Spyre Therapeutics stock slides 6.6% after New Year session; $30 level and 2026 trial data in focus

NEW YORK, January 3, 2026, 20:15 ET — Market closed Spyre Therapeutics, Inc. shares fell 6.6% on Friday to $30.58, finishing the first U.S. trading day of 2026 near the lower end of the session’s $30.11-$33.31 range. The stock remains below its 52-week high of $34.49 after trading about 889,000 shares, while biotech benchmarks were little changed. The slide stands out because small-cap biotech names can swing sharply when investors reset positioning at the start of the year, especially after thin holiday liquidity. With little fresh company news since the last quarterly update, traders are leaning more heavily on macro
Klaviyo stock drops nearly 10% as 2026 opens — what KVYO investors watch next

Klaviyo stock drops nearly 10% as 2026 opens — what KVYO investors watch next

NEW YORK, Jan 3, 2026, 19:55 ET — Market closed Shares of Klaviyo (KVYO) closed down 9.7% on Friday at $29.32, marking a sharp slide on the first trading day of 2026. The move matters now because investors began the new year with a fresh rate backdrop: U.S. Treasury yields climbed, and growth stocks lagged as traders recalibrated expectations for Federal Reserve policy and upcoming data. Reuters Klaviyo’s drop also puts attention back on what the company says about 2026 demand and margins when it next reports results, with the earnings date currently estimated for Feb. 18. Nasdaq U.S. stocks
Pony AI stock jumps nearly 11% after CLSA starts coverage; what traders watch next

Pony AI stock jumps nearly 11% after CLSA starts coverage; what traders watch next

NEW YORK, Jan 3, 2026, 19:34 ET — Market closed Pony AI Inc shares surged 10.8% on Friday to close at $16.07, and were last down 0.4% at $16.00 in after-hours trading, according to Investing.com data. Investing The move matters because Pony AI sits in a high-volatility corner of the market — autonomous driving — where incremental catalysts like new analyst coverage can move the stock sharply, especially at the start of a new year when portfolios are being reset. MarketBeat The rally also came as investors weighed appetite for “AI plays” more broadly after Wall Street opened 2026 with

Stock Market Today

iFAST share price drops 3% as markets shut; earnings next week in focus

iFAST share price drops 3% as markets shut; earnings next week in focus

7 February 2026
iFAST shares fell 3.2% to S$9.64 in heavy trading Friday, closing near the day’s low as investors awaited FY2025 results due Feb. 12. The stock is about 13% below its 52-week high. iFAST recently agreed to buy a 30% stake in Financial Alliance for S$19.6 million, pending regulatory approval. Assets under administration stood at S$30.62 billion as of Sept. 30.
Sembcorp Industries share price: what to watch after Friday dip as Feb 25 results near

Sembcorp Industries share price: what to watch after Friday dip as Feb 25 results near

7 February 2026
Sembcorp shares closed at S$6.05 on Friday, down 0.33%, as Singapore’s STI dropped 0.8%. Shareholders approved the A$6.5 billion Alinta Energy takeover on Jan 30, but the deal still faces regulatory and closing conditions. Sembcorp will release FY2025 results on Feb 25 before market open. Trading volume reached about 4.3 million shares.
Hongkong Land share price drops 4% despite fresh buyback — what investors watch next

Hongkong Land share price drops 4% despite fresh buyback — what investors watch next

7 February 2026
Hongkong Land shares fell 4.2% to US$8.18 in Singapore on Friday after the company disclosed a buyback of 170,000 shares at US$8.5252 each on Feb. 5, with plans to cancel them. The drop followed a volatile week marked by a new Singapore real estate fund launch and an expanded buyback programme. Investors are watching for the group’s annual results on March 5.
Go toTop